Pulmonary Precancerous Condition

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS other · 2015-02-18
Clinical Trial Update: Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung [Phase 1]
Phase 1 trial of erlotinib hydrochloride for prevention of cancer in patients with precancerous lung lesions was terminated.